These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 30873707)

  • 1. Impact of delisting high-strength opioid formulations from a public drug benefit formulary on opioid utilization in Ontario, Canada.
    Martins D; Khuu W; Tadrous M; Juurlink DN; Mamdani MM; Paterson JM; Gomes T;
    Pharmacoepidemiol Drug Saf; 2019 May; 28(5):726-733. PubMed ID: 30873707
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluating the early impacts of delisting high-strength opioids on patterns of prescribing in Ontario.
    Guan Q; Khuu W; Martins D; Tadrous M; Chiu M; Do MT; Gomes T
    Health Promot Chronic Dis Prev Can; 2018 Jun; 38(6):256-262. PubMed ID: 29911823
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trends and Patterns of Geographic Variation in Opioid Prescribing Practices by State, United States, 2006-2017.
    Schieber LZ; Guy GP; Seth P; Young R; Mattson CL; Mikosz CA; Schieber RA
    JAMA Netw Open; 2019 Mar; 2(3):e190665. PubMed ID: 30874783
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of Iowa's Prescription Monitoring Program on Opioid Pain Reliever Prescribing Patterns: An Interrupted Time Series Study 2003-2014.
    Ranapurwala SI; Carnahan RM; Brown G; Hinman J; Casteel C
    Pain Med; 2019 Feb; 20(2):290-300. PubMed ID: 29509935
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of changes in opioid funding and clinical policies on rapid tapering of opioids in Ontario, Canada.
    Martins D; Khuu W; Tadrous M; Greaves S; Sproule B; Bozinoff N; Juurlink DN; Mamdani MM; Paterson JM; Gomes T;
    Pain; 2022 Jan; 163(1):e129-e136. PubMed ID: 34326293
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impacts of the New York State COVID-19 disaster emergency orders on prescription dispensing for opioids and medication for opioid use disorder.
    Suri A; Feaster DJ; Balise RR; Quinn J; Nunes EV; Gilbert L; El-Bassel N; Rundle AG
    Addiction; 2023 Apr; 118(4):711-718. PubMed ID: 36398540
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of Florida's prescription drug monitoring program and pill mill law on high-risk patients: A comparative interrupted time series analysis.
    Chang HY; Murimi I; Faul M; Rutkow L; Alexander GC
    Pharmacoepidemiol Drug Saf; 2018 Apr; 27(4):422-429. PubMed ID: 29488663
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of Florida's Prescription Drug Monitoring Program and Pill Mill Laws on Opioid Prescribing and Use.
    Rutkow L; Chang HY; Daubresse M; Webster DW; Stuart EA; Alexander GC
    JAMA Intern Med; 2015 Oct; 175(10):1642-9. PubMed ID: 26280092
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of prescription drug monitoring programs (PDMPs) on opioid utilization among Medicare beneficiaries in 10 US States.
    Moyo P; Simoni-Wastila L; Griffin BA; Onukwugha E; Harrington D; Alexander GC; Palumbo F
    Addiction; 2017 Oct; 112(10):1784-1796. PubMed ID: 28498498
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluating the population-level effects of oxycodone restrictions on prescription opioid utilization in Ontario.
    Rudoler D; Kurdyak P; Gomes T; Huang A; Jones W; Littleford S; Paracha N; Fischer B
    Pharmacoepidemiol Drug Saf; 2022 Jul; 31(7):769-778. PubMed ID: 35470515
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prescription opioid characteristics at initiation for non-cancer pain and risk of treated opioid use disorder: A population-based study.
    Papadomanolakis-Pakis N; Moore KM; Peng Y; Gomes T
    Drug Alcohol Depend; 2021 Apr; 221():108601. PubMed ID: 33618194
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Impact of Increased Hydrocodone Regulation on Opioid Prescribing in an Urban Safety-Net Health Care System.
    Northrup TF; Carroll K; Suchting R; Villarreal YR; Zare M; Stotts AL
    J Am Board Fam Med; 2019; 32(3):362-374. PubMed ID: 31068400
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trends in prescriptions for oxycodone and other commonly used opioids in the United States, 2000-2010.
    Kenan K; Mack K; Paulozzi L
    Open Med; 2012; 6(2):e41-7. PubMed ID: 23696768
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prescription Drug Monitoring Programs Are Associated With Sustained Reductions In Opioid Prescribing By Physicians.
    Bao Y; Pan Y; Taylor A; Radakrishnan S; Luo F; Pincus HA; Schackman BR
    Health Aff (Millwood); 2016 Jun; 35(6):1045-51. PubMed ID: 27269021
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of prescription drug monitoring programs and pill mill laws on high-risk opioid prescribers: A comparative interrupted time series analysis.
    Chang HY; Lyapustina T; Rutkow L; Daubresse M; Richey M; Faul M; Stuart EA; Alexander GC
    Drug Alcohol Depend; 2016 Aug; 165():1-8. PubMed ID: 27264166
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Opioid Prescribing After Surgery in the United States, Canada, and Sweden.
    Ladha KS; Neuman MD; Broms G; Bethell J; Bateman BT; Wijeysundera DN; Bell M; Hallqvist L; Svensson T; Newcomb CW; Brensinger CM; Gaskins LJ; Wunsch H
    JAMA Netw Open; 2019 Sep; 2(9):e1910734. PubMed ID: 31483475
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regional and Rural-Urban Variation in Opioid Prescribing in the Veterans Health Administration.
    Lund BC; Ohl ME; Hadlandsmyth K; Mosher HJ
    Mil Med; 2019 Dec; 184(11-12):894-900. PubMed ID: 31111908
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Controlled Substance Prescribing Patterns--Prescription Behavior Surveillance System, Eight States, 2013.
    Paulozzi LJ; Strickler GK; Kreiner PW; Koris CM;
    MMWR Surveill Summ; 2015 Oct; 64(9):1-14. PubMed ID: 26469747
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alternatives to Opioid Education and a Prescription Drug Monitoring Program Cumulatively Decreased Outpatient Opioid Prescriptions.
    Sigal A; Shah A; Onderdonk A; Deaner T; Schlappy D; Barbera C
    Pain Med; 2021 Feb; 22(2):499-505. PubMed ID: 33067993
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mandatory Review of Prescription Drug Monitoring Program Before Issuance of a Controlled Substance Results in Overall Reduction of Prescriptions Including Opioids and Benzodiazepines.
    Manders L; Abd-Elsayed A
    Pain Physician; 2020 Jun; 23(3):299-304. PubMed ID: 32517396
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.